Mode
Text Size
Log in / Sign up
Phase 3 Completed N=28 Randomized Quadruple-blind Treatment

Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse

Suicidal Ideation · Depression · Alcohol Abuse
Source: ClinicalTrials.gov NCT03539887 ↗
Enrolled (actual)
28
Serious AEs
0.0%
Results posted
Mar 2023
Primary outcomePrimary: Suicidal Ideation as Assessed by the Scale for Suicide Ideation (SSI) — 10.8; 12.3 score on a scale
◆ Published Evidence
Emerging
13citations · ~7 / year
A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of the Acute Antisuicidal and Antidepressant Effects of Intranasal (R,S)-Ketamine in Severe Unipolar and Bipolar Depression With and Without Comorbid Alcohol Use Disorder.
The Journal of clinical psychiatry · 2024 · Likely link

Summary

This project aims to evaluate the potential rapid and sustained antisuicidal and antidepressant effects of a single intranasal dose of ketamine in inpatients during a mood episode in Major Depressive Disorder (MDD) or Bipolar Disorder (BD) with or without comorbid recent abuse of alcohol.

Linked Publications

  • A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of the Acute Antisuicidal and Antidepressant Effects of Intranasal (R,S)-Ketamine in Severe Unipolar and Bipolar Depression With and Without Comorbid Alcohol Use Disorder.
    The Journal of clinical psychiatry · 2024 · 13 citations · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Suicidal Ideation as Assessed by the Scale for Suicide Ideation (SSI)
10.8; 12.3
SECONDARY
Depression as Assessed by the Montgomery-Åsberg Depression Rating Scale (MADRS)
16.8; 22.5
SECONDARY
Snaith-Hamilton Pleasure Scale
4.12; 5.00
SECONDARY
Alcohol Urge Questionnaire (AUQ)
13.8; 16.3
SECONDARY
Manic Symptoms as Assessed by Score on the Young Mania Rating Scale (YMRS)
2.29; 2.40
SECONDARY
Dissociative State as Assessed by Score on Clinician-Administered Dissociative States Scale (CADSS)
0.824; 1.60

Eligibility Criteria

Inclusion Criteria

  • Voluntary admission to Harris County Psychiatry Center
  • Able to provide written informed consent
  • Current suicidal ideation and depressive symptoms and Diagnostic and Statistical Manual of Mental Disorders -IV- Text Revision(DSM-IV-TR) depressive episode (also MADRS greater than or equal to 12) and Young Mania Rating Scale (YMRS) score lower than 8
  • DSM-IV-TR criteria for current alcohol abuse (but not intoxicated/withdrawal, abstinent from drinking for > 5 days prior to admission).
  • Lifetime history of suicide attempt (patient)
  • Not taking any medication in the last 24hs.
  • Scale for Suicide Ideation (SSI) score over 4 (first five items) and Columbia scale (C-SSRS) score 4 or 5

Exclusion Criteria

  • Unstable medical condition or medical problem with known central nervous system (CNS) effects, e.g. uncontrolled hypertension systolic blood pressure (SBP) ≥170 and/or diastolic blood pressure (DBP) ≥100) or recent history (6 months) of alcohol-withdrawal seizures or significant abnormal laboratory tests (liver function test (LFT) 3 times higher than normal).
  • Prior diagnosis of a DSM-IV-TR psychotic spectrum disorder, psychotic symptoms, or personality disorder.
  • Currently under the acute effects of an illicit substance.
  • Pregnant or nursing women.
  • Subjects with a history of DSM-IV drug dependency or abuse (except for caffeine or nicotine dependence) within the preceding 3 months
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03539887) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search